Value-based Reimbursement as a Mechanism to Achieve Social and Financial Impact in the Healthcare System.

health policy payment reform value-based health care value-based reimbursement

Journal

Journal of health economics and outcomes research
ISSN: 2327-2236
Titre abrégé: J Health Econ Outcomes Res
Pays: United States
ID NLM: 101648581

Informations de publication

Date de publication:
2023
Historique:
received: 14 10 2023
accepted: 15 10 2023
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: epublish

Résumé

Value-based reimbursement strategies have been considered in the continuous search for establishing a sustainable healthcare system. For models that have been already implemented, success is demonstrated according to specific details of the patients' consumption profile based on their clinical condition and the risk balance among all the stakeholders. From fee-for-service to value-based bundled payment strategies, the manner in which accurate patient-level cost and outcome information are used varies, resulting in different risk agreements between stakeholders. A thorough understanding of value-based reimbursement agreements that views such agreements as a mechanism for risk management is critical to the task of ensuring that the healthcare system generates social impacts while ensuring financial sustainability. This perspective article focuses on a critical analysis of the impact of value-based reimbursement strategies on the healthcare system from a social and financial perspective. A critical analysis of the literature about value-based reimbursement was used to identify how these strategies impact healthcare systems. The literature analysis was followed by the conceptual description of value-based reimbursement agreements as mechanisms for achieving social and financial impacts on the healthcare system. There is no single successful path toward payment reform. Payment reform is used as a strategy to re-engineer the way in which the system is organized to provide care to patients, and its successful implementation leads to cultural, social, and financial changes. Stakeholders have reached consensus regarding the claim that the use of value reimbursement strategies and business models could increase efficiency and generate social impact by reducing healthcare inequity and improving population health. However, the successful implementation of such new strategies involves financial and social risks that require better management by all the stakeholders. The use of cutting-edge technologies are essential advances to manage these risks and must be paired with strong leadership focusing on the directive to improve population health and, consequently, value. Payment reform is used as a mechanism to re-engineer how the system is organized to deliver care to patients, and its successful implementation is expected to result in social and financial modifications to the healthcare system.

Identifiants

pubmed: 37928822
doi: 10.36469/001c.89151
pii: 89151
pmc: PMC10621730
doi:

Types de publication

Editorial

Langues

eng

Pagination

100-103

Références

J Arthroplasty. 2017 Aug;32(8):2590-2597
pubmed: 28438453
Health Policy. 2017 Jul;121(7):755-763
pubmed: 28535996
N Engl J Med. 1996 Oct 17;335(16):1227-31
pubmed: 8815948
Harv Bus Rev. 2016 Jul-Aug;94(7-8):88-98, 100, 134
pubmed: 27526565
JAMA. 2022 Oct 25;328(16):1592-1594
pubmed: 36282270
Circ Cardiovasc Qual Outcomes. 2020 May;13(5):e006483
pubmed: 32393125
N Engl J Med. 2018 Jul 19;379(3):260-269
pubmed: 30021090
JAMA. 2022 Oct 25;328(16):1616-1623
pubmed: 36282256
N Engl J Med. 2015 Apr 30;372(18):1681-4
pubmed: 25923546
Health Aff (Millwood). 2020 Jan;39(1):50-57
pubmed: 31905061
Anesth Analg. 2018 Jul;127(1):317
pubmed: 29734241
Value Health. 2020 Jun;23(6):812-823
pubmed: 32540239
Harv Bus Rev. 2016 Jul-Aug;94(7-8):102-11, 134
pubmed: 27526566
Am J Med. 2020 May;133(5):528-529
pubmed: 31954115
Health Care Manag (Frederick). 2008 Apr-Jun;27(2):104-12
pubmed: 18475111
Healthc Financ Manage. 2014 Jun;68(6):76-83
pubmed: 24968629
Sultan Qaboos Univ Med J. 2020 Aug;20(3):e260-e270
pubmed: 33110640
J Neurointerv Surg. 2016 May;8(5):547-8
pubmed: 25829366

Auteurs

Ana Paula Beck de Silva Etges (APB)

Avant-garde Health, Boston, Massachusetts.
National Institute of Science and Technology for Health Technology Assessment, Porto Alegre, Brazil.
Graduate Program in Epidemiology Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil.

Harry H Liu (HH)

Avant-garde Health, Boston, Massachusetts.

Porter Jones (P)

Avant-garde Health, Boston, Massachusetts.

Carisi A Polanczyk (CA)

National Institute of Science and Technology for Health Technology Assessment, Porto Alegre, Brazil.
Graduate Program in Epidemiology Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil.

Classifications MeSH